20% OFF EVERYTHING· CodeNEW20
Ends October 31Shop now
Lot certificates published
Plain, secure packaging
Back to Research Articles
Tissue Repair & Regeneration

TB-500 and Thymosin Beta-4: Actin Sequestration and Tissue-Repair Mechanisms

The acetylated seven-residue fragment discussed as TB-500 corresponds to an actin-binding domain of Thymosin Beta-4 (Tβ4). The parent's actin and cell-migration findings do not establish the isolated fragment's function.

Purely Peptides Research TeamJuly 16, 2026Updated: Jul 21, 20268 min read
TB-500thymosin beta-4actintissue repaircardioprotectionILK
Research Use Only. All compounds discussed are sold exclusively for laboratory and in vitro research purposes. Nothing on this page constitutes medical advice or recommendation for human use.

Thymosin Beta-4 (Tβ4) is a 43-amino acid protein found in virtually all mammalian cells. The synthetic fragment discussed here as TB-500 is Ac-LKKTETQ: seven residues corresponding to residues 17–23 of mature human Tβ4, within its actin-binding domain, with N-terminal acetylation on leucine. Esposito et al. identified this structure in a TB-500 preparation; the product designation alone does not uniquely specify a molecular structure.

Tβ4's G-actin sequestration is documented. Sharing a sequence with its actin-binding domain does not establish that the isolated acetylated fragment reproduces that function. The Tβ4 studies discussed below also do not establish ILK activation or the same cell-migration and tissue-repair responses for Ac-LKKTETQ.

G-Actin Sequestration

Tβ4's primary function is sequestration of G-actin (monomeric actin) in a 1:1 complex, modulating the G:F actin equilibrium. By buffering available G-actin, Tβ4 controls the rate and direction of actin polymerization — translating to directed lamellipodia formation and accelerated cell migration toward wound sites. Keratinocytes, fibroblasts, and endothelial cells treated with Tβ4 show significantly increased migration in scratch assay models.

Integrin-Linked Kinase (ILK) Upregulation

Tβ4 upregulates ILK, a serine/threonine kinase at focal adhesions that activates Akt/PKB and β-catenin survival and proliferation pathways. In mice after coronary artery ligation, Bock-Marquette et al. (2004) reported increased cardiac ILK and Akt activity and greater early myocyte survival after Tβ4 exposure.

Cardiovascular Research

Studies from Smart et al. (MRC, UK) demonstrated Tβ4 reactivates embryonic cardiac progenitors in the adult epicardium. In mice after coronary artery ligation, Bock-Marquette et al. (2004) reported improved cardiac function after Tβ4 exposure.

Tissue Repair

In a corneal-repair model, Tβ4-containing formulations accelerated epithelial repair versus vehicle controls in the referenced study.

TB-500 is a component of our Glow Blend:

Glow Blend — View Product Page →

References

  1. Goldstein AL, Hannappel E, Kleinman HK. (2005). Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med, 11(9), 421–429.
  2. Smart N, et al. (2007). Thymosin β4 induces adult epicardial progenitor mobilization. Nature, 445(7124), 177–182.
  3. Sosne G, et al. (2010). Thymosin beta 4 and corneal wound healing. Ann NY Acad Sci, 1194, 190–198.
  4. Bock-Marquette I, et al. (2004). Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432(7016), 466–472. doi:10.1038/nature03000.
  5. Esposito S, et al. (2012). Synthesis and characterization of the N-terminal acetylated 17–23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal, 4(9), 733–738. PMID: 22962027.

This article summarizes publicly available research for educational purposes and does not constitute medical advice, a therapeutic claim, or a recommendation for human use. Products referenced are sold for laboratory research use only.

What the studies reported

Each finding describes one cited study in its stated model. These observations are specific to that study and do not establish effects in other settings.

Thymosin beta-4

Cell and tissue studies

Animal studies

  • Wild-type mice following unilateral ureteral obstruction

    In wild-type mice following unilateral ureteral obstruction, the study reported reduced late fibrosis with Tβ4 alone and increased fibrosis when Tβ4 was combined with a prolyl oligopeptidase inhibitor.

    Zuo Y et al., Kidney international, 2013
  • PAI-1 knockout mice following unilateral ureteral obstruction

    In PAI-1 knockout mice following unilateral ureteral obstruction, the study reported that both the profibrotic effects of Tβ4 plus prolyl oligopeptidase inhibition and the late reparative effects of Tβ4 alone were absent.

    Zuo Y et al., Kidney international, 2013
All findings and references in the Research Library

TB-500

Animal studies

  • Plasma and urine from horses

    Ho et al. detected N-acetylated LKKTETQ and its metabolites by liquid chromatography–mass spectrometry in plasma and urine from horses following TB-500 administration.

    Ho EN et al., Journal of chromatography. A, 2012
All findings and references in the Research Library

Research Compounds Discussed